Irinotecan-induced interstitial pneumonia.
Michielin
O
O
Multidisciplinary Oncology Center, University Hospital, Lausanne, Switzerland.
Udry
E
E
Périard
D
D
Matzinger
O
O
Lobrinus
J A
JA
Stupp
R
R
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003937:Diagnosis, Differential; D005625:Frontal Lobe; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D000077146:Irinotecan; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008297:Male; D011859:Radiography; D000077204:Temozolomide
D000077146:Irinotecan; D003606:Dacarbazine; D002166:Camptothecin; D000077204:Temozolomide